C07D 277/46
By carboxylic acids, or sulfur or nitrogen analogues thereof
Official title: by carboxylic acids, or sulfur or nitrogen analogues thereof
C07D277/46 (By carboxylic acids, or sulfur or nitrogen analogues thereof) appears on 667 US grants and 624 published applications in this corpus.
Search patents in C07D- Granted patents
- 667
- Published applications
- 624
- Assignees
- 367
- Inventors
- 2,246
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 7 | 0 |
| 1978 | 12 | 0 |
| 1979 | 9 | 0 |
| 1980 | 11 | 0 |
| 1981 | 13 | 0 |
| 1982 | 5 | 0 |
| 1983 | 7 | 0 |
| 1984 | 5 | 0 |
| 1985 | 12 | 0 |
| 1986 | 10 | 0 |
| 1987 | 9 | 0 |
| 1988 | 10 | 0 |
| 1989 | 9 | 0 |
| 1990 | 9 | 0 |
| 1991 | 9 | 0 |
| 1992 | 5 | 0 |
| 1993 | 17 | 0 |
| 1994 | 10 | 0 |
| 1995 | 11 | 0 |
| 1996 | 10 | 0 |
| 1997 | 8 | 0 |
| 1998 | 5 | 0 |
| 1999 | 10 | 0 |
| 2000 | 11 | 0 |
| 2001 | 15 | 2 |
| 2002 | 11 | 15 |
| 2003 | 10 | 21 |
| 2004 | 13 | 41 |
| 2005 | 15 | 43 |
| 2006 | 15 | 37 |
| 2007 | 19 | 36 |
| 2008 | 23 | 43 |
| 2009 | 26 | 37 |
| 2010 | 27 | 49 |
| 2011 | 28 | 21 |
| 2012 | 34 | 23 |
| 2013 | 18 | 20 |
| 2014 | 26 | 26 |
| 2015 | 20 | 26 |
| 2016 | 17 | 17 |
| 2017 | 23 | 22 |
| 2018 | 13 | 21 |
| 2019 | 24 | 16 |
| 2020 | 10 | 12 |
| 2021 | 11 | 19 |
| 2022 | 9 | 19 |
| 2023 | 7 | 17 |
| 2024 | 8 | 21 |
| 2025 | 8 | 15 |
| 2026 | 6 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- BAF complex modulating compounds21 Jul 2026US 12,685,735 B2Foghorn Therapeutics Inc.
- Substituted aminothiazoles as DGKzeta inhibitors for immune activation7 Jul 2026US 12,673,927 B2Deutsches Krebsforschungszentrum
- Inhibiting USP3631 Mar 2026US 12,590,087 B2Valo Health, Inc.
- SMARCA inhibitors and uses thereof10 Mar 2026US 12,569,485 B2Kymera Therapeutics, Inc.
- MYC inhibitors and uses thereof10 Feb 2026US 12,545,654 B2StemSynergy Therapeutics, Inc.
- Usp2 inhibitors and methods of using the same for the treatment of diseases20 Aug 2026US 2026/0242394 A1Beth Israel Deaconess Medical Center, Inc.
- Adar1 inhibitors and methods of using the same16 Jul 2026US 2026/0200890 A1Aten Porus Lifesciences Pvt. Ltd.
- Novel enantiomers of a series of antiviral compounds21 May 2026US 2026/0137669 A1Innovative Molecules GmbH
- (2,4-dichlorophenoxy)acetic acid analogs12 Feb 2026US 2026/0042731 A1Corteva Agriscience LLC
- Inhibitors of Glutathione S-Transferases (GSTS) and NAD(P)H:Quinone Oxidoreductase 1 (NQO1), Pharmaceutical Compositions, and Uses in Managing Cancer29 Jan 2026US 2026/0027088 A1Emory University
Most cited
By later US patents
- Heterocyclic self-immolative linkers and conjugates164US 7,375,078 B2Genentech, Inc. · 2008
- Glutaramide diuretic agents156US 5,030,654 APfizer Inc. · 1991
- Aryl carbonyl derivatives as therapeutic agents152US 7,384,967 B2Novo Nordisk A/S · 2008
- Thiazolylacetamido cephalosporin type compounds148US 4,098,888 ATakeda Chemical Industries, Ltd. · 1978
- Heterocyclic self-immolative linkers and conjugates134US 7,754,681 B2Seattle Genetics, Inc. · 2010